Cardiva Medical Garners $12,500,000 New Financing

  • Feed Type
  • Date
  • Company Name
    Cardiva Medical
  • Mailing Address
    888 W. Maude Avenue Sunnyvale, CA 94085 USA
  • Company Description
    Cardiva Medical is committed to developing a new standard of care for vascular access site management. Cardiva has developed an innovative approach to safe, secure vascular access site management without leaving anything behind in the artery or tissue tract.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The funds will provide working capital as the company continues to ramp up the commercialization of its vascular closure product line, which includes Cardiva Catalyst and VASCADE. VASCADE was approved by the FDA in 2013, and approved for CE marking in 2012. Catalyst II and Catalyst III were cleared for marketing by the FDA in 2007 and 2009, respectively.
  • M&A Terms
  • Venture Investor

Trending on Xconomy